Nicox to distribute AdenoPlus in Japan, releases Q2 earnings

Nicox announced it has entered into an exclusive agreement with Nitto Medic to distribute AdenoPlus in Japan, according to a company press release.The agreement stipulates Nitto Medic will become the exclusive distributor of AdenoPlus — a diagnostic test for acute conjunctivitis — in Japan and will be responsible for securing regulatory approval in Japan before the test’s anticipated launch within the next 18 months.